Boosting immune responses during malaria remains a challenge. Overcoming T cell exhaustion by blocking coinhibitory receptors offers a promising lead.
References
Hafalla, J.C., Silvie, O. & Matuschewski, K. Immunol. Rev. 240, 297–316 (2011).
Butler, N. et al. Nat. Immunol. 13, 188–195 (2012).
Freeman, G.J., Wherry, E.J., Ahmed, R. & Sharpe, A.H. J. Exp. Med. 203, 2223–2227 (2006).
Wherry, E.J. et al. Immunity 27, 670–684 (2007).
Blackburn, S.D. et al. Nat. Immunol. 10, 29–37 (2009).
Barber, D.L. et al. Nature 439, 682–687 (2006).
Keir, M.E., Butte, M.J., Freeman, G.J. & Sharpe, A.H. Annu. Rev. Immunol. 26, 677–704 (2008).
Goldberg, M.V. & Drake, C.G. Curr. Top. Microbiol. Immunol. 344, 269–278 (2011).
Porichis, F. et al. Blood 118, 965–974 (2011).
Fourcade, J. et al. J. Exp. Med. 207, 2175–2186 (2010).
Matsuzaki, J. et al. Proc. Natl. Acad. Sci. USA 107, 7875–7880 (2010).
Hodi, F.S. et al. N. Engl. J. Med. 363, 711–723 (2010).
Brahmer, J.R. et al. J. Clin. Oncol. 28, 3167–3175 (2010).
Jin, H.T. et al. Proc. Natl. Acad. Sci. USA 107, 14733–14738 (2010).
Brooks, D.G. et al. Proc. Natl. Acad. Sci. USA 105, 20428–20433 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.J.F. and A.H.S. have patents in the PD-1 field and receive patent royalties.
Rights and permissions
About this article
Cite this article
Freeman, G., Sharpe, A. A new therapeutic strategy for malaria: targeting T cell exhaustion. Nat Immunol 13, 113–115 (2012). https://doi.org/10.1038/ni.2211
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2211
- Springer Nature America, Inc.
This article is cited by
-
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
BMC Cancer (2019)
-
Parasites and immunotherapy: with or against?
Journal of Parasitic Diseases (2016)
-
Ribonucleic acid (RNA) biosynthesis in human cancer
Cancer Cell International (2015)
-
Combination cancer immunotherapy and new immunomodulatory targets
Nature Reviews Drug Discovery (2015)